top of page

This site was designed with the

website builder. Create your website today.Start Now

WELCOME

Search

Clearside Biomedical presents new data from CLS-AX ODYSSEY phase 2b trial

Grace Koennecke
Feb 11
0 min read

Recent Posts

ZEISS VISULAS Combi availability expands to Canada

ZEISS VISULAS Combi availability expands to Canada

HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease

HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease

Innovent Biologics announces approval of SYCUME in China for thyroid eye disease

Innovent Biologics announces approval of SYCUME in China for thyroid eye disease

コメント

bottom of page